Intermittent Administration of Helminth-Derived Fh15 Modulates Gut Microbiota and Partially Mitigates Dysbiosis in Early Stages of Severe Experimental Colitis
International Journal of Molecular Sciences · 02.05.2026 · 27 (9) · 4068
DOI: 10.3390/ijms27094068 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.05.2026. Verfasst von María Del Mar Figueroa-Gispert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR 00936, USA. Hauptthemen laut MEDLINE: Dysbiosis, Gastrointestinal Microbiome, Colitis, Helminth Proteins. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, NIGMS NIH HHS, National Institutes of Health NIGMS.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by dysbiosis of the gut microbiota. Helminth infections are known to modulate host immunity and intestinal microbial composition; however, the therapeutic use of live parasites poses safety challenges. The recombinant Fasciola hepatica fatty acid-binding protein Fh15 is a helminth-derived molecule with anti-inflammatory effects in models of septic shock and dextran sulfate sodium (DSS)-induced colitis. Whether Fh15 also influences gut microbial composition during colitis remains unknown. Male C57BL/6 mice received 4% DSS in drinking water for 7 days to induce colitis and were treated intraperitoneally with Fh15 (2 mg/kg) on days 1, 3, and 5. Fecal samples were collected on days 2, 4, and 7 for 16S rRNA gene sequencing. Standard microbiota pipelines were used to evaluate community diversity. Acute DSS treatment disrupted gut microbial diversity and community structure compared with non-colitic controls. Fh15 treatment partially restored early microbial balance by shifting microbial composition toward that of healthy mice and reducing microbial dispersion, indicating enhanced community stability despite severe dysbiosis. Although alpha diversity did not return to control levels, Fh15 mitigated the expansion of pro-inflammatory genera (Enterococcus and Turicibacter) and preserved beneficial taxa, including Adlercreutzia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR 00936, USA.
ORCID-Profile: María Del Mar Figueroa-Gispert, Natalie M Meléndez-Vázquez, Ana M Espino, Filipa Godoy-Vitorino
Förderung
- NIMHD NIH HHS
- NIGMS NIH HHS
- National Institutes of Health NIGMS
- National Institutes of Health NIAID
- NIAID
Zitieren
APA
Figueroa-Gispert, M. D. M., Meléndez-Vázquez, N. M., Espino, A. M., & Godoy-Vitorino, F. (2026). Intermittent Administration of Helminth-Derived Fh15 Modulates Gut Microbiota and Partially Mitigates Dysbiosis in Early Stages of Severe Experimental Colitis. International Journal of Molecular Sciences, 27(9), 4068. https://doi.org/10.3390/ijms27094068
Vancouver
Figueroa-Gispert MDM, Meléndez-Vázquez NM, Espino AM, Godoy-Vitorino F. Intermittent Administration of Helminth-Derived Fh15 Modulates Gut Microbiota and Partially Mitigates Dysbiosis in Early Stages of Severe Experimental Colitis. International Journal of Molecular Sciences. 2026;27(9):4068. doi:10.3390/ijms27094068
BibTeX
@article{FigueroaGispert2026,
author = {Figueroa-Gispert, María Del Mar and Meléndez-Vázquez, Natalie M and Espino, Ana M and Godoy-Vitorino, Filipa},
title = {Intermittent Administration of Helminth-Derived Fh15 Modulates Gut Microbiota and Partially Mitigates Dysbiosis in Early Stages of Severe Experimental Colitis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {4068},
doi = {10.3390/ijms27094068}
}
EUVIMED